H00007031-M02
antibody from Abnova Corporation
Targeting: TFF1
BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00007031-M02 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#H00007031-M02, RRID:AB_464044
- Product name
- TFF1 monoclonal antibody (M02), clone 3H5
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against a full length recombinant TFF1.
- Antigen sequence
MATMENKVICALVLVSMLALGTLAEAQTETCTVAP
RERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFY
PNTIDVPPEEECEF- Isotype
- IgG
- Antibody clone number
- 3H5
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Submitted references CRK7 modifies the MAPK pathway and influences the response to endocrine therapy.
Iorns E, Martens-de Kemp SR, Lord CJ, Ashworth A
Carcinogenesis 2009 Oct;30(10):1696-701
Carcinogenesis 2009 Oct;30(10):1696-701
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Detection limit for recombinant GST tagged TFF1 is approximately 0.3ng/ml as a capture antibody.
- Validation comment
- Sandwich ELISA (Recombinant protein)
- Protocol
- Protocol